Two plasmid mammalian expression system
OwnerVishwas Joshiinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerVishwas Joshiinventor
Estimating the term…
Reverse engineering has offered new ways of studying the pathology of RNA viral infections, new more efficient devices of synthesizing recombinant viruses and developing vaccines and also demonstrated the versatility and efficiency of RNA dependent RNA polymerase RDRP system as an expression system. However, the currently used methods require a repertoire of complex, difficult-to-use tools. Present invention describes, a simpler plasmid based mammalian expression system that uses the RDRP enzyme activity for expression of recombinant proteins or RNA from viral minigenomes and rescue of recombinant viruses from cDNAs encoding entire genome(s) of negative stranded RNA viruses. This system will be useful for expression of recombinant proteins, therapeutic RNA molecules including anti-sense and/or selecting interfering RNA and Ribozymes. This system can also be used for gene therapy and producing recombinant viruses for production of new vaccines.
1-19. (canceled)
A two plasmid system for producing recombinant proteins using RNA Dependent RNA Polymerase of non-segmented negative strand RNA viruses comprising:
A two plasmid system for producing infectious non-segmented negative strand RNA viruses using
A two plasmid system for producing recombinant proteins using Measles virus RNA Dependent RNA Polymerase of non-segmented negative strand RNA viruses comprising:
A two plasmid system for producing infectious measles virus comprising:
A method of producing recombinant measles viruses comprising:
Dependencies are inferred from the claim text.